A Daily Weight-Loss Pill Worked Just as Well for Women at Every Stage of Menopause, New Trial Data Show
New analyses of the ATTAIN trials presented at the European Association for the Study of Diabetes found orforglipron cut body weight by up to 14 per cent regardless of whether women were premenopausal, perimenopausal or postmenopausal.
Sep 29, 2026


